<?xml version="1.0" encoding="UTF-8"?>
<p>In another paper (
 <xref rid="B378" ref-type="bibr">Panyod et al., 2020</xref>), 11 medicinal plants were discussed concerning their 
 <italic>in vitro</italic> antiviral activity using different models. Two species (
 <italic>Allium sativum</italic> L. and 
 <italic>Zingiber officinale</italic> Roscoe) mentioned in this study that had their 
 <italic>in vitro</italic> potential and immune capacity assessed, were also included in our study. Moreover, in an elegant evidence-based analysis, eighteen phytotherapeutic preparations were mentioned as having some role in the clinical management of viral respiratory diseases, showing different levels of immunological response (
 <xref rid="B392" ref-type="bibr">Portella et al., 2020</xref>). Four plants mentioned in that report [
 <italic>Echinacea purpurea</italic>
 <bold>(</bold>L.) Moench, 
 <italic>Glycyrrhiza glabra</italic> L.
 <italic>, Sambucus nigra</italic> L., and 
 <italic>Scutellaria baicalensis</italic> Georgi] were also included in our study.
</p>
